Skip to content

Reusable Mlyocardial Biopsy Forceps (Bioptomes

by Dlp, Inc. 510(k)

Active United States

510(k) K890453

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK890453 Date31 Mar 1989ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DWZ
Device Class
Class II
Regulation
21 CFR Part 870.4075
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Reusable Myocardial Biopsy Forceps (Bioptomes) is an endomyocardial biopsy device designed for obtaining tissue samples from the heart muscle. Classified as a Class II medical device under FDA regulation 870.4075, it is intended for use in cardiovascular procedures to facilitate diagnostic evaluations of myocardial tissue.

This reusable device is supplied sterile and intended for single-use per procedure, adhering to FDA 510(k) clearance (K890453) under the Cardiovascular advisory committee. It is not MRI-safe, and proper sterilization and storage protocols must be followed between uses. The device is regulated under product code DWZ and is intended for use in clinical settings by trained healthcare professionals.

Other devices from Dlp, Inc.

See all devices from Dlp, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • How is the Reusable Myocardial Biopsy Forceps (Bioptomes) intended to be used in clinical settings?

    The Reusable Myocardial Biopsy Forceps (Bioptomes) is designed for obtaining tissue samples from the heart muscle during endomyocardial biopsy procedures. It is intended for use by trained healthcare professionals in cardiovascular settings to help diagnose myocardial tissue conditions by facilitating tissue sampling for further pathological evaluation.

  • Is the device meant for single-use or can it be reused between patients?

    While the device is labeled as reusable, it is explicitly intended for single-use per procedure to ensure sterility and safety. Between uses, it must undergo proper sterilization and storage protocols as outlined by the manufacturer to maintain its integrity and prevent cross-contamination.

  • What storage and handling requirements should be followed for this device?

    The device is supplied sterile, but since it is reusable, it requires strict adherence to sterilization protocols between uses. It is not MRI-safe, so it must be stored and handled in a way that avoids exposure to MRI environments. Proper storage conditions, as specified by the manufacturer, should be followed to preserve its functionality and sterility.

  • What regulatory pathway was followed for FDA clearance of this device?

    The Reusable Myocardial Biopsy Forceps (Bioptomes) received FDA clearance through a Traditional 510(k) pathway under the Cardiovascular Advisory Committee. The clearance (K890453) was granted in 1989, with the device classified as substantially equivalent to a predicate under FDA regulation 870.4075 and assigned product code DWZ.